Phase II study of semisynthetic paclitaxel in metastatic breast cancer.
European Journal of Cancer Part A: General Topics.
Times cited: 10
Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor.
Journal of the National Cancer Institute.
Times cited: 81